Skip to content

Clinical trials

Cardiomyopathies trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: Norway Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20152
20161
20182
20191
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Enrolling by invitation2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals3
Oslo University Hospital2
Bayer1
Intellia Therapeutics1
LHL Helse1
Medtronic Cardiac Rhythm and Heart Failure1
Pfizer1
St. Olavs Hospital1
Universitaire Ziekenhuizen KU Leuven1
University Hospital, Akershus1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies13
Heart Failure6
Amyloidosis4
Amyloidosis, Familial2
Bundle-Branch Block1
Cardiomyopathy, Dilated1
Cardiovascular Diseases1
Edema1
Heart Diseases1
Pulmonary Disease, Chronic Obstructive1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.